A 38-year-old woman presents to the outpatient clinic with a 3-month history of palpitations, heat intolerance, and weight loss despite increased appetite. On examination, she has a resting heart rate of 110 bpm, fine tremor of the outstretched hands, and a diffuse thyroid enlargement without nodules. Her eyes appear prominent with lid lag. Laboratory investigations show: TSH 0.01 mIU/L (normal 0.4–4.0), free T4 18 pg/dL (normal 0.8–1.8), free T3 6.2 pg/mL (normal 2.3–4.2). Thyroid peroxidase (TPO) antibodies and thyroglobulin antibodies are negative. A radioiodine uptake scan shows diffuse increased uptake. What is the most likely diagnosis?

Explanation

## Clinical Diagnosis: Graves' Disease ### Key Clinical Features **Key Point:** Graves' disease is the most common cause of hyperthyroidism (60–80% of cases), characterized by autoimmune thyroid stimulation via TSH receptor antibodies (TRAb). This patient presents with the classic triad: 1. **Hyperthyroid symptoms:** palpitations, heat intolerance, weight loss, tremor 2. **Diffuse thyroid enlargement (goiter)** without nodules 3. **Ophthalmologic signs:** lid lag and exophthalmos (eye prominence) — pathognomonic for Graves' disease ### Laboratory Interpretation | Parameter | Value | Interpretation | |-----------|-------|----------------| | TSH | 0.01 mIU/L | Suppressed (primary hyperthyroidism) | | Free T4 | 18 pg/dL | Elevated | | Free T3 | 6.2 pg/mL | Elevated | | TPO/Thyroglobulin Ab | Negative | Rules out Hashimoto's overlap; TRAb would be positive in Graves' | | Radioiodine uptake | Diffuse increased | Confirms thyroid hormone synthesis (not release from stored hormone) | **High-Yield:** Negative TPO antibodies do NOT exclude Graves' disease—only TRAb (TSH receptor antibodies) are specific. The diffuse uptake pattern on radioiodine scan is diagnostic of Graves' (vs. nodular uptake in toxic multinodular goiter). ### Why Graves' and Not Other Causes? **Clinical Pearl:** The combination of **diffuse goiter + exophthalmos + diffuse radioiodine uptake** is virtually pathognomonic for Graves' disease. Exophthalmos (and orbital tissue inflammation) occurs ONLY in Graves' disease among hyperthyroid conditions, due to TSH receptor expression in orbital fibroblasts and preadipocytes. ### Pathophysiology ```mermaid flowchart TD A[Autoimmune activation of B/T cells]:::outcome --> B[TSH receptor antibodies IgG]:::outcome B --> C[Bind to TSH receptor on thyroid]:::action C --> D[Stimulate thyroid hormone synthesis & release]:::action D --> E[Elevated T3/T4, suppressed TSH]:::outcome B --> F[Cross-react with orbital fibroblasts]:::action F --> G[Orbital inflammation & exophthalmos]:::outcome ``` **Mnemonic:** **GRAVES** = **G**oiter + **R**aised T3/T4 + **A**ntibodies (TRAb) + **V**ery suppressed TSH + **E**xophthalmos + **S**ymptomatic (palpitations, tremor) ### Management Principles 1. **Antithyroid drugs** (PTU, methimazole) — first-line 2. **Beta-blockers** for symptom relief 3. **Radioiodine** or **thyroidectomy** for definitive treatment 4. **Ophthalmology referral** for exophthalmos (may require immunosuppression or orbital decompression if severe) [cite:Harrison 21e Ch 405]